The 2026 Biotech Reckoning: Enough With the AI Hype, Show Me the EfficacyGlobal Report·1 day ago, 04:12 AMGENB+2.43%IBRX-0.28%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 31 at 12:05 PMMBRX+6.25%NUWE-7.47%
Crude Oil Gains 1%; Apple Shares Tumble After Q3 Resultsbenzinga_article·Jul 31 at 11:02 AMNWL+13.57%FET+12.25%
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga_article·Jul 31 at 07:15 AMAMZN+4.58%KPTI+2.60%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Jul 31 at 07:05 AMNUWE-7.47%REPL+6.34%
This Edison International Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Fridaybenzinga_article·Jul 31 at 06:20 AMUPBD+4.69%KPTI+2.60%
Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarketbenzinga_article·Jul 31 at 03:50 AMAMZN+4.58%REPL+6.34%
Karyopharm Stock (KPTI) Crashes After Hours: Here's What's Driving the Movebenzinga_article·Jul 31 at 12:25 AMKPTI+2.60%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jul 30 at 04:05 PMNUWE-7.47%QURE+0.99%
Karyopharm plans August sNDA filing seeking FDA priority review for selinexor-ruxolitinib in myelofibrosisPUBT·Jul 30 at 03:24 PMKPTI+2.60%
Karyopharm says Phase 3 selinexor maintenance trial in endometrial cancer misses PFS endpointPUBT·Jul 30 at 03:18 PMKPTI+2.60%
